Remove 2003 Remove Pharma Companies Remove Pharmaceuticals Remove Research
article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

Here, DDW’s Megan Thomas highlights the research taking place and where this is happening. This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture.

Drugs 189
article thumbnail

AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 ‘Long Haulers’Institutional Review Board Authorizes Public Notification for Potential Enrollment of Subjects

The Pharma Data

In addition, many survivors of the first SARS-CoV-1 epidemic in 2003 continued to report classic chronic fatigue-like symptoms after recovering from the acute illness. Studies show that patients who recover from COVID-19 can report the persistence of symptoms (See: JAMA Network ). See: PLOS ONE ). AIM CEO Thomas K. About AIM ImmunoTech Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Decentralised identities: Blockchain based informed consent

Drug Discovery World

An investigation by Lentz and co-workers from the Clinical Trials Transformation Initiative (CTTI) identified four key topics as areas for improvement in Informed Consent: defining an effective ICP, training research staff, improving the informed consent document (ICF) and exploring the use of eConsent 2. Ther Innov Regul Sci.

article thumbnail

Decentralised identities: Blockchain based informed consent

Drug Discovery World

An investigation by Lentz and co-workers from the Clinical Trials Transformation Initiative (CTTI) identified four key topics as areas for improvement in Informed Consent: defining an effective ICP, training research staff, improving the informed consent document (ICF) and exploring the use of eConsent 2. Ther Innov Regul Sci.